Journal of Clinical Endocrinology & Metabolism, Vol 81, 2595-2600, Copyright © 1996 by Endocrine Society

ARTICLES

Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies

P Rodien, AM Madec, J Ruf, F Rajas, H Bornet, P Carayon and J Orgiazzi
INSERM U-449, Faculte de Medecine R. Laennec, Lyon, France.

Thyroid antibody-dependent cell-mediated cytotoxicity (ADCC) has been reported in autoimmune thyroid disease, and its relationship with antithyroperoxidase antibodies (TPOAb) questioned. We studied the effect of highly purified human thyroperoxidase (TPO) on thyroid ADCC activity elicited by serum from patients with autoimmune thyroid disease. ADCC promoted by a pool of Graves' disease sera could be inhibited by the addition of TPO in a dose-dependent manner. TPO at 40 micrograms/mL decreased the ADCC observed in the presence of this serum pool by 50%. In the presence of 40 micrograms/mL TPO, ADCC was significantly reduced (P < 0.0005) from 39.6 +/- 10.6% (mean +/- SD) to 14.0 +/- 12.9% for the 18 Graves' disease sera tested and from 39.1 +/- 10.5% to 6.1 +/- 1.7% for the 16 thyroiditis sera tested. Purified thyroglobulin had no effect. Immunoaffinity-purified TPOAb could mediate ADCC in a dose-dependent manner, whereas purified antithyroglobulin antibodies could not. Three TPOAb-positive, but ADCC- negative, sera appear to contain an activity able to protect thyroid cells from ADCC. This protective effect is also observed on human fibroblasts. In conclusion, TPO is the major antigen involved in thyroid ADCC.

This article has been cited by other articles:

				E. E. Wasserman, K. Nelson, N. R. Rose, W. Eaton, J. P. Pillion, E. Seaberg, M. V. Talor, L. Burek, A. Duggan, and R. H. Yolken Maternal Thyroid Autoantibodies during the Third Trimester and Hearing Deficits in Children: An Epidemiologic Assessment Am. J. Epidemiol., March 15, 2008; 167(6): 701 - 710. [Abstract] [Full Text] [PDF]

				S. A. Rebuffat, B. Nguyen, B. Robert, F. Castex, and S. Peraldi-Roux Antithyroperoxidase Antibody-Dependent Cytotoxicity in Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 929 - 934. [Abstract] [Full Text] [PDF]

				S. A. Rebuffat, D. Bresson, B. Nguyen, and S. Peraldi-Roux The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified Int. Immunol., July 1, 2006; 18(7): 1091 - 1099. [Abstract] [Full Text] [PDF]

				H. P. Ng and A. W. C. Kung Induction of Autoimmune Thyroiditis and Hypothyroidism by Immunization of Immunoactive T Cell Epitope of Thyroid Peroxidase Endocrinology, June 1, 2006; 147(6): 3085 - 3092. [Abstract] [Full Text] [PDF]

				J. Guo, S. M. McLachlan, P. N. Pichurin, C.-R. Chen, N. Pham, H. A. Aliesky, C. S. David, and B. Rapoport Relationship between Thyroid Peroxidase T Cell Epitope Restriction and Antibody Recognition of the Autoantibody Immunodominant Region in Human Leukocyte Antigen DR3 Transgenic Mice Endocrinology, November 1, 2005; 146(11): 4961 - 4967. [Abstract] [Full Text] [PDF]

				D. Bresson, S. A. Rebuffat, B. Nguyen, J. P. Banga, A. Gardas, and S. Peraldi-Roux New Insights into the Conformational Dominant Epitopes on Thyroid Peroxidase Recognized by Human Autoantibodies Endocrinology, June 1, 2005; 146(6): 2834 - 2844. [Abstract] [Full Text] [PDF]

				D. Bresson, M. Pugniere, F. Roquet, S. A. Rebuffat, B. N-Guyen, M. Cerutti, J. Guo, S. M. McLachlan, B. Rapoport, V. Estienne, et al. Directed Mutagenesis in Region 713-720 of Human Thyroperoxidase Assigns 713KFPED717 Residues as Being Involved in the B Domain of the Discontinuous Immunodominant Region Recognized by Human Autoantibodies J. Biol. Chem., September 10, 2004; 279(37): 39058 - 39067. [Abstract] [Full Text] [PDF]

				H. P. Ng, J. Paul Banga, and A. W. C. Kung Development of a Murine Model of Autoimmune Thyroiditis Induced with Homologous Mouse Thyroid Peroxidase Endocrinology, February 1, 2004; 145(2): 809 - 816. [Abstract] [Full Text] [PDF]

				D. Bresson, M. Cerutti, G. Devauchelle, M. Pugniere, F. Roquet, C. Bes, C. Bossard, T. Chardes, and S. Peraldi-Roux Localization of the Discontinuous Immunodominant Region Recognized by Human Anti-thyroperoxidase Autoantibodies in Autoimmune Thyroid Diseases J. Biol. Chem., March 7, 2003; 278(11): 9560 - 9569. [Abstract] [Full Text] [PDF]

				V. Estienne, C. Duthoit, S. Blanchin, R. Montserret, J.-M. Durand-Gorde, M. Chartier, D. Baty, P. Carayon, and J. Ruf Analysis of a conformational B cell epitope of human thyroid peroxidase: identification of a tyrosine residue at a strategic location for immunodominance Int. Immunol., April 1, 2002; 14(4): 359 - 366. [Abstract] [Full Text] [PDF]

				J. Guo, X.-M. Yan, S. M. McLachlan, and B. Rapoport Search for the Autoantibody Immunodominant Region on Thyroid Peroxidase: Epitopic Footprinting with a Human Monoclonal Autoantibody Locates a Facet on the Native Antigen Containing a Highly Conformational Epitope J. Immunol., January 15, 2001; 166(2): 1327 - 1333. [Abstract] [Full Text] [PDF]

				V. Estienne, C. Blanchet, P. Niccoli-Sire, C. Duthoit, J.-M. Durand-Gorde, C. Geourjon, D. Baty, P. Carayon, and J. Ruf Molecular Model, Calcium Sensitivity, and Disease Specificity of a Conformational Thyroperoxidase B-cell Epitope J. Biol. Chem., December 10, 1999; 274(50): 35313 - 35317. [Abstract] [Full Text] [PDF]

				P. P. A. Smyth, S. G. Shering, M. T. Kilbane, M. J. Murray, E. W. M. McDermott, D. F. Smith, and N. J. O’Higgins Serum Thyroid Peroxidase Autoantibodies, Thyroid Volume, and Outcome in Breast Carcinoma J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2711 - 2716. [Abstract] [Full Text]

				V. Estienne, C. Duthoit, L. Vinet, J.-M. Durand-Gorde, P. Carayon, and J. Ruf A Conformational B-cell Epitope on the C-terminal End of the Extracellular Part of Human Thyroid Peroxidase J. Biol. Chem., April 3, 1998; 273(14): 8056 - 8062. [Abstract] [Full Text] [PDF]

				J. Guo, J. C. Jaume, B. Rapoport, and S. M. McLachlan Recombinant Thyroid Peroxidase-Specific Fab Converted to Immunoglobulin G (IgG) Molecules: Evidence for Thyroid Cell Damage by IgG1, but Not IgG4, Autoantibodies J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 925 - 931. [Abstract] [Full Text] [PDF]